JUST IN: Mindray Rumored To Go Private In PE Buyout
This article was originally published in PharmAsia News
Executive Summary
China’s largest medical device maker, U.S.-listed Mindray, could be the latest healthcare company to delist and be taken private in a move to unlock value.
You may also be interested in...
China Planning To Ban Gene Editing Technology Exports
Beijing’s latest proposal to ban gene editing is viewed as a direct response to Washington’s tightening grip over the transfer of US technology to China.
Chinese Balloon Affair To Blow Up US Health Collaboration?
The latest surveillance balloon downing could torpedo improving bilateral health collaboration between China and the US at a time when warming ties are crucial to solving a flurry of gridlocks.
Chinese Balloon Affair To Blow Up US Health Collaboration?
The latest surveillance balloon downing could torpedo improving bilateral health collaboration between China and the US at a time when warming ties are crucial to solving a flurry of gridlocks.